Select Medical Corp. Senior Notes Assigned B-' Rating; Recovery Rating '6' May 12

  • ID: 2127558
  • May 2012
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) May 7, 2012--Standard & Poor's Ratings Services said today that it assigned ratings to the proposed $365 million senior notes due 2020 to be issued by Select Medical Corp. We rated the notes 'B-' (two notches lower than the 'B+' corporate credit rating on the company) with a recovery rating of '6', indicating our expectation of negligible (0% to 10%) recovery for lenders in the event of a payment default. The proceeds of this issue will refinance Select's outstanding subordinated notes due 2015. The corporate credit rating on Select is 'B+' and the rating outlook is stable. The rating reflects our assessment of the company's business risk profile as "weak" (according to our criteria) because...

Companies mentioned in this report are:
- Select Medical Corp.

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Select Medical Corp.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.